搜索临床试验以:BIA 3-202
总计13372个结果
-
University of North Carolina, Chapel HillUniversity of Maryland, Baltimore; National Eye Institute (NEI); Orbis完全的
-
Suzhou Kintor Pharmaceutical Inc,Suzhou Koshine Biomedica, Inc.主动,不招人
-
China National Center for Cardiovascular Diseases完全的
-
Boehringer Ingelheim完全的
-
Royal Marsden NHS Foundation TrustMerck KGaA, Darmstadt, Germany; 4SC AG未知
-
Gunkang Pharmaceuticals, Inc招聘中
-
University of HawaiiGlaxoSmithKline招聘中
-
Chiesi Farmaceutici S.p.A.完全的中度至重度慢性阻塞性肺疾病 (COPD)保加利亚, 德国, 匈牙利, 波兰, 俄罗斯联邦, 英国
-
Regeneron Pharmaceuticals完全的
-
Federico II University未知
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, France完全的
-
Johns Hopkins Bloomberg School of Public HealthNative American Research Centers for Health; White Mountain Apache Tribe主动,不招人
-
Institute of Hematology & Blood Diseases Hospital尚未招聘鲁索替尼对 AA HSCT 受者的 aGVHD 的预防价值
-
Tehran University of Medical Sciences完全的
-
Bio-K Plus International Inc.Centre hospitalier de l'Université de Montréal (CHUM)终止
-
Vascular Biogenics Ltd. operating as VBL Therapeutics完全的
-
Tranzyme, Inc.完全的